• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2025, Vol. 27 ›› Issue (4): 546-551.DOI: 10.3969/j.issn.1671-2587.2025.04.017

• 个例报告 • 上一篇    下一篇

p.Cys247Arg纯合错义变异致凝血因子Ⅻ缺陷症1个家系遗传学分析*

吴可1, 贾文浩2, 宋静娟2   

  1. 1浙江大学医学院附属第一医院,浙江杭州 310003;
    2浙江大学医学院附属邵逸夫医院,浙江杭州 310016
  • 收稿日期:2025-03-06 出版日期:2025-08-20 发布日期:2025-08-22
  • 通讯作者: 宋静娟,主要从事临床检验诊断学研究,(E-mail)songjingjuan@zju.edu.cn。
  • 作者简介:吴可,主要从事凝血方面研究,(E-mail)ruby0227@126.com。并列第一作者:贾文浩,主要从事凝血方向研究,(E-mail)15990081379@163.com。
  • 基金资助:
    *本课题受浙江省医药卫生科技项目(No.2024KY1127)资助

Analysis of the Mechanism of p.Cys247Arg Homozygous Missense Variation Leading to the Activity Defect of Hereditary Coagulation Factor Ⅻ

WU Ke1, JIA Wenhao2, SONG Jingjuan2   

  1. 1The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310003;
    2Sir Run Run Shao Hopital Zhejiang University School of Medicine, Hangzhou 310016
  • Received:2025-03-06 Online:2025-08-20 Published:2025-08-22

摘要: 目的 探讨1例近亲婚配家庭中因凝血因子Ⅻ(coagulation factor Ⅻ, FⅫ)基因第8外显子存在c.826T>C(p.Cys247Arg)纯合错义突变导致的FⅫ缺陷症,及其临床表型和基因变异,初步分析其分子致病机制。方法 以2023年10月13日因捐献干细胞体检时发现凝血功能异常的1例遗传性FⅫ缺陷症男性先证者及其家系成员(3代5人)作为研究对象,对先证者及其家系成员的凝血功能相关指标进行检测。采用DNA直接测序技术,对先证者的F12基因进行了全面检测,并对家系成员中相应的变异位点区域进行分析。通过生物信息学软件,我们对变异位点进行了潜在致病性评估。结果 先证者活化部分凝血活酶时间(activated partial thromboplastin time, APTT)明显延长,为158.4 s,APTT纠正试验可纠正。先证者的FⅫ活性(FⅫ activity, FⅫ:C)和FⅫ抗原(FⅫ antigen, FⅫ:Ag)分别为0%和2%。F12基因第8外显子存在c.826T>C(p.Cys247Arg)纯合错义突变;其父亲和母亲均携带该变异的杂合子。使用生物信息学软件分析结果:Cys247显示出高度的进化保守性,并且该变异位点被鉴定为具有致病性。结论 该家系F12基因第8外显子c.826T>C错义变异可能与该家系FⅫ水平减低有关;c.826T>C错义变异为国际上首次报道。

关键词: F12基因, Kringle结构, 基因突变, 凝血因子Ⅻ缺陷

Abstract: Objective To analyze the clinical phenotype and genetic variation of a consanguineously married family with deficiency resulting from a homozygous missense mutation c.826T>C (p.Cys247Arg) in exon 8 of the coagulation factor Ⅻ (FⅫ) gene, and investigate the molecular mechanism. Methods A male proband with hereditary FⅫ deficiency, who was found to have abnormal coagulation function during a physical examination for hematopoietic stem cell donation on October 13, 2023, and his family members (five individuals across three generations) were selected as the research subjects. Using direct DNA sequencing technology, we conducted a comprehensive analysis of the F12 gene in the proband, which included the determination of all exons and their flanking sequences, as well as the analysis of corresponding variant regions in family members. The potential pathogenicity of the variant sites was assessed using bioinformatics software. Results The proband activated partial thromboplastin time (APTT) was significantly prolonged to 158.4 seconds, while the APTT mixing test showed correction. The proband's Factor Ⅻ activity (FⅫ:C ) and Factor Ⅻ antigen (FⅫ:Ag ) were 0% and 2% respectively. A homozygous missense mutation c.826T>C (p.Cys247Arg) was identified in exon 8 of the F12 gene, with both the father and mother being heterozygous carriers of this variant. Bioinformatics software analysis revealed that Cys247 is highly evolutionarily conserved, and this variant was determined to be pathogenic. Conclusion The c.826T>C variation in exon 8 of F12 gene might be associated with the decreased level of FⅫ in this family, and this variation was first reported in the world.

Key words: F12 gene, Kringle structure, Gene variation, Coagulation factor Ⅻ deficiency

中图分类号: